Skip to main content
NUTRITION 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Clinical Nutrition (Poster Session)

(P03-061-24) Modification of Risk for All-Cause and Cardiovascular Disease-Related Mortality With Changes in the Body Mass Index: A Prospective Cohort Study With 12 Years Follow Up

Sunday, June 30, 2024
12:45 PM – 1:45 PM CT
Location: Poster Board 217

    Presenting Author(s)

  • YY

    Yung-Feng Yen

    Taipei City Hospital, Yangming Branch
    Taipei City, Taipei, Taiwan (Republic of China)

    • Co-Author(s)

  • PK

    Po-Wen Ku, Prof.

    National Chung Hsing University, Graduate Institute of Sports and Health Management, Taiwan (Republic of China)

  • YL

    Yun-Ju Lai, Dr.

    Puli Branch of Taichung Veterans General Hospital, Division of Endocrinology and Metabolism, Department of Internal Medicine, Taiwan (Republic of China)

  • ES

    Emmanuel Stamatakis, Prof.

    University of Sydney, Charles Perkins Centre, Australia

Objectives: The longitudinal impact of changes in body mass index (BMI) on the risk of all-cause and cardiovascular disease (CVD)-related mortality has not been extensively studied. We examined whether changes in BMI status over time are associated with risk of all-cause and CVD-related mortality.

Methods: This longitudinal study recruited 90,258 adults between 2002-2008 from the Taiwan MJ cohort who underwent repeated BMI measurements at an interval of 3.3 years and were followed up for all-cause and CVD-related mortality over 12.1 years. Cox proportional hazard and Fine-Gray sub-distribution hazard models with death from non-CVD causes as the competing risk were used to determine the impact of changes in BMI status on the risk of all-cause or CVD-related mortality, respectively.

Results: Over 1,094,606 person-years of follow-up, 2,084 participants died, including 391 (18.8%) CVD-related deaths. After adjusting for other covariates, >10% increase (adjusted hazard ratio [aHR], 1.36; 95% confidence interval [CI], 1.09-1.70) or >10% decrease of BMI (aHR, 1.86; 95% CI, 1.43-2.43) was significantly associated with higher risk of all-cause mortality, compared with stable BMI. Participants with obesity at baseline who had BMI increase of >10% during the follow-up period had a significantly higher risk of all-cause (aHR = 2.30; 95% CI:1.38-3.85) and CVD-related mortality (aHR = 3.44; 95% CI:1.33-8.89).

Conclusions: A >10% increase in BMI in individuals with obesity was significantly associated with a higher risk of all-cause and CVD-related mortality. Our findings suggest that individuals with adiposity should adopt measures to reduce body weight to prevent premature mortality.

Funding Sources: This study was supported by the Australian National Health and Medical Research Council Investigator Grant (APP1194510).